AsthmaBrain Status
The company received an undisclosed amount of development capital from Muir Equity in 2015.
Developer of application to predict and prevent asthma attacks by using historical and perpetual analysis of patient populations to identify asthma-related risks. The company's Neural Intelligence Systems (NIS) enable payors, providers and patients to predict and prevent asthma attacks, simply and organically, using real-time data, unique deep learning technology and automated alerts.
Year Founded
2015
General Information
-
Website
-
Business Status
Generating Revenue
-
Ownership Status
Privately Held (backing)
-
Financing Status
Private Equity-Backed
AsthmaBrain News and Updates
Asthma Outcomes Improved With Use of Mindfulness-Based Stress Reduction
Pulmonology Advisor | October 3, 2022
Ventilators Market Demand, Supply, Growth Factors, Latest Rising Trend and Forecast to 2029
openPR | September 21, 2022
Common steroids used for asthma, allergies linked to brain decline, study finds
CNN Philippines | August 31, 2022
How asthma may cut brain tumor risk
Futurity: Research News | December 27, 2021
AsthmaBrain's Verticals
AsthmaBrain Primary Industry Sector / Group / Code
AsthmaBrain's Trends
Headquarters
-
HQ Address Line 11311 Sutter Street
-
HQ Address Line 2Suite 202
-
HQ CitySan Francisco
-
HQ State/ProvinceCalifornia
-
HQ Post Code94109
-
HQ CountryUnited States
AsthmaBrain's Keywords
mood_badFeed is empty.
Add a review